|
IARS expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.785200E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.231000E-01 |
| Normal-vs-Stage2 |
2.029200E-01 |
| Normal-vs-Stage3 |
1.416500E-02 |
| Normal-vs-Stage4 |
3.644800E-01 |
| Stage1-vs-Stage2 |
2.440400E-01 |
| Stage1-vs-Stage3 |
1.167630E-02 |
| Stage1-vs-Stage4 |
3.047400E-01 |
| Stage2-vs-Stage3 |
2.337700E-02 |
| Stage2-vs-Stage4 |
9.764000E-02 |
| Stage3-vs-Stage4 |
4.666600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.308400E-01 |
| Normal-vs-AfricanAmerican |
7.207900E-02 |
| Normal-vs-Asian |
9.051800E-01 |
| Caucasian-vs-AfricanAmerican |
2.739000E-01 |
| Caucasian-vs-Asian |
6.705800E-01 |
| AfricanAmerican-vs-Asian |
2.595400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.140800E-01 |
| Normal-vs-Female |
8.160000E-01 |
| Male-vs-Female |
1.627840E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.865000E-01 |
| Normal-vs-Age(41-60Yrs) |
3.291400E-01 |
| Normal-vs-Age(61-80Yrs) |
6.020800E-01 |
| Normal-vs-Age(81-100Yrs) |
2.716000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.914400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.986400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.950200E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.855200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.577400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.986600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.749760E-01 |
| Classical-VS-Follicular |
3.072600E-01 |
| Classical-VS-Other |
1.427860E-02 |
| Classical-VS-Normal |
8.215400E-01 |
| Tall-VS-Follicular |
8.251500E-02 |
| Tall-VS-Other |
2.652000E-01 |
| Tall-VS-Normal |
1.500770E-01 |
| Follicular-VS-Other |
6.523500E-03 |
| Follicular-VS-Normal |
3.718800E-01 |
| Other-VS-Normal |
7.941100E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.234400E-01 |
| Normal-vs-N1 |
7.319700E-02 |
| N0-vs-N1 |
1.024840E-01 |
|
|
